Page last updated: 2024-10-25

amphetamine and Astrocytosis

amphetamine has been researched along with Astrocytosis in 9 studies

Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.

Research Excerpts

ExcerptRelevanceReference
"Astrocytosis, a process in which astrocytes undergo proliferation and enhancement of glial fibrillary acidic protein (GFAP) expression, has been suggested to play important roles in the maintenance of dependence to amphetamine and its derivatives."7.79Maintenance of amphetamine-induced place preference does not correlate with astrocytosis. ( Gramage, E; Herradón, G; Martín, YB, 2013)
"The dopamine-releasing and depleting substance amphetamine (AMPH) can make cortical neurons susceptible to damage, and the prevention of hyperthermia, seizures and stroke is thought to block these effects."7.71Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke. ( Bowyer, JF; Jakab, RL, 2002)
"The dopamine-releasing and depleting substance amphetamine (AMPH) can make cortical neurons susceptible to damage, and the prevention of hyperthermia, seizures and stroke is thought to block these effects."3.71Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke. ( Bowyer, JF; Jakab, RL, 2002)
" These results suggest that the chronic administration of clobenzorex may decrease motor function in a manner similar to amphetamine, via the neuroadaptive and non-neurotoxic changes caused to the striatum under this administration scheme."1.62The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration. ( Apóstol Del Rosal, GD; Limón, ID; Martínez, I; Patricio-Martínez, A, 2021)
"Amphetamine (AMPH) is a psychostimulant whose chronic abuse may cause impairments in attention and memory in humans."1.33Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway. ( Cadet, JL; Krasnova, IN; Ladenheim, B, 2005)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's4 (44.44)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Apóstol Del Rosal, GD1
Limón, ID1
Martínez, I1
Patricio-Martínez, A1
Tripathy, D1
Haobam, R1
Nair, R1
Mohanakumar, KP1
Gramage, E3
Putelli, A1
Polanco, MJ1
González-Martín, C1
Ezquerra, L1
Alguacil, LF1
Pérez-Pinera, P1
Deuel, TF1
Herradón, G3
Martín, YB2
Ramanah, P1
Pérez-García, C1
Jakab, RL1
Bowyer, JF1
Krasnova, IN1
Ladenheim, B1
Cadet, JL1
McCoy, MK1
Martinez, TN1
Ruhn, KA1
Szymkowski, DE1
Smith, CG1
Botterman, BR1
Tansey, KE1
Tansey, MG1
Silva-Araújo, AL1
Tavares, MA1

Other Studies

9 other studies available for amphetamine and Astrocytosis

ArticleYear
The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration.
    Neurotoxicity research, 2021, Volume: 39, Issue:5

    Topics: Administration, Oral; Amphetamine; Amphetamines; Animals; Corpus Striatum; Dopamine Uptake Inhibitor

2021
Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Amphetamine; Animals; Cell Differentiation; Embryonic Stem Cells; Gliosis; Immunohistochemistry; Mal

2013
The neurotrophic factor pleiotrophin modulates amphetamine-seeking behaviour and amphetamine-induced neurotoxic effects: evidence from pleiotrophin knockout mice.
    Addiction biology, 2010, Volume: 15, Issue:4

    Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Carrier Proteins; Cell Survival; Conditioning,

2010
Midkine regulates amphetamine-induced astrocytosis in striatum but has no effects on amphetamine-induced striatal dopaminergic denervation and addictive effects: functional differences between pleiotrophin and midkine.
    Neuroscience, 2011, Sep-08, Volume: 190

    Topics: Amphetamine; Animals; Astrocytes; Carrier Proteins; Central Nervous System Stimulants; Conditioning,

2011
Maintenance of amphetamine-induced place preference does not correlate with astrocytosis.
    European journal of pharmacology, 2013, Jan-15, Volume: 699, Issue:1-3

    Topics: Amphetamine; Animals; Astrocytes; Carrier Proteins; Caudate Nucleus; Conditioning, Psychological; Cy

2013
Parvalbumin neuron circuits and microglia in three dopamine-poor cortical regions remain sensitive to amphetamine exposure in the absence of hyperthermia, seizure and stroke.
    Brain research, 2002, Dec-20, Volume: 958, Issue:1

    Topics: Amphetamine; Animals; Astrocytes; Cerebral Cortex; Dopamine; Drug Residues; Fever; Glial Fibrillary

2002
Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:7

    Topics: Amphetamine; Animals; Apoptosis; bcl-2-Associated X Protein; Calbindins; Caspase 3; Caspases; Corpus

2005
Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Sep-13, Volume: 26, Issue:37

    Topics: Amphetamine; Animals; Cell Death; Cells, Cultured; Coculture Techniques; Disease Models, Animal; Dop

2006
Expression of glial fibrillary acidic protein in the rat retina after exposure to psychostimulants.
    Retina (Philadelphia, Pa.), 1995, Volume: 15, Issue:3

    Topics: Amphetamine; Animals; Animals, Newborn; Astrocytes; Central Nervous System Stimulants; Cocaine; Fema

1995